Temat: "Patents" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: More Cash, Less Innovation: The Effect of the American Jobs Creation Act on Patent Value.
Autorzy :: Almeida, Heitor (AUTHOR)
Hsu, Po-Hsuan (AUTHOR)
Li, Dongmei (AUTHOR)
Tseng, Kevin (AUTHOR); Pokaż więcej
Źródło :: Journal of Financial & Quantitative Analysis. Feb2021, Vol. 56 Issue 1, p1-28. 28p.
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
Autorzy :: Motari M; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya. .
Nikiema JB; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.
Kasilo OMJ; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.
Kniazkov S; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.
Loua A; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.
Sougou A; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.
Tumusiime P; Adjunct Faculty, Daystar University School of Law, Nairobi, Kenya.; Pokaż więcej
Źródło :: BMC public health [BMC Public Health] 2021 Mar 11; Vol. 21 (1), pp. 490. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :: Historical Article; Journal Article
MeSH Terms :: Intellectual Property*
Patents as Topic*
COVID-19/*prevention & control
Commerce/*legislation & jurisprudence
Health Services Accessibility/*economics
Health Services Accessibility/*legislation & jurisprudence
Africa ; Commerce/history ; Developing Countries ; History, 20th Century ; Humans ; International Law ; Public Health/legislation & jurisprudence ; World Health Organization
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Pool patents to get COVID vaccines and drugs to all.
Autorzy :: Billette de Villemeur E
Dequiedt V
Versaevel B; Pokaż więcej
Źródło :: Nature [Nature] 2021 Mar; Vol. 591 (7851), pp. 529.
Typ publikacji :: Letter
MeSH Terms :: COVID-19 Vaccines*/economics
COVID-19 Vaccines*/supply & distribution
Licensure*/legislation & jurisprudence
Patents as Topic*/legislation & jurisprudence
COVID-19/*drug therapy
Drug Industry/*economics
Drugs, Generic/*economics
Drugs, Generic/*supply & distribution
COVID-19/economics ; Drug Development/economics ; Humans ; World Health Organization/organization & administration
SCR Protocol :: COVID-19 drug treatment
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Digital Instruments as Invention Machines.
Autorzy :: KOUTROUMPIS, PANTELIS
LEIPONEN, AIJA
THOMAS, LLEWELLYN D. W.; Pokaż więcej
Źródło :: Communications of the ACM. Jan2021, Vol. 64 Issue 1, p70-78. 9p. 1 Color Photograph, 3 Charts, 3 Graphs.
: Periodyk

Szczegóły Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Prospection of recent chitosan biomedical trends: Evidence from patent analysis (2009-2020).
Autorzy :: Kurakula M; Department of Biomedical Engineering, The University of Memphis, Memphis, TN 38152, USA. Electronic address: .
N NR; Department of Pharmaceutics, Annamacharya College of Pharmacy, New Boyanapalli, Rajampet, Andhra Pradesh 516126, India. Electronic address: .; Pokaż więcej
Źródło :: International journal of biological macromolecules [Int J Biol Macromol] 2020 Dec 15; Vol. 165 (Pt B), pp. 1924-1938. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Biomedical Research*
Patents as Topic*
Chitosan/*chemistry
Chitosan/toxicity ; Polymerization ; Publications
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: South Africa and India push for COVID-19 patents ban.
Autorzy :: Usher AD; Pokaż więcej
Źródło :: Lancet (London, England) [Lancet] 2020 Dec 05; Vol. 396 (10265), pp. 1790-1791.
Typ publikacji :: Journal Article
MeSH Terms :: Healthcare Disparities*
Patents as Topic*
COVID-19 Vaccines/*supply & distribution
COVID-19 ; Humans ; India ; Pandemics ; South Africa
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Patent citation network analysis: A perspective from descriptive statistics and ERGMs.
Autorzy :: Chakraborty M; Faculty of Informatics, Universitá della Svizzera italiana, Lugano, Switzerland.
Byshkin M; Faculty of Informatics, Universitá della Svizzera italiana, Lugano, Switzerland.
Crestani F; Faculty of Informatics, Universitá della Svizzera italiana, Lugano, Switzerland.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Dec 03; Vol. 15 (12), pp. e0241797. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Bibliometrics*
Patents as Topic*
Humans
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape.
Autorzy :: Lyu L; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Feng Y; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Chen X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Hu Y; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. .; Pokaż więcej
Źródło :: Nature biotechnology [Nat Biotechnol] 2020 Dec; Vol. 38 (12), pp. 1387-1394.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Immunotherapy, Adoptive*
Patents as Topic*
Receptors, Chimeric Antigen/*metabolism
Cooperative Behavior ; Geography ; Humans ; Publications
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
Autorzy :: Murza A; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.
Dion SP; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.
Boudreault PL; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.
Désilets A; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.
Leduc R; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.
Marsault É; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.; Pokaż więcej
Źródło :: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2020 Nov; Vol. 30 (11), pp. 807-824. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Patents as Topic*
Coronavirus Infections/*complications
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*complications
Pneumonia, Viral/*drug therapy
Respiratory Tract Diseases/*drug therapy
Respiratory Tract Diseases/*etiology
Serine Endopeptidases/*metabolism
Serine Proteinase Inhibitors/*therapeutic use
COVID-19 ; Humans ; Pandemics ; Respiratory Tract Diseases/enzymology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: [The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care].
Autorzy :: Gómez Franco T; Doctor en Economía aplicada. Profesor de Economía, Universidad Carlos III de Madrid, Madrid, España. .
Matarín Rodríguez-Peral E; Doctora en Ciencias de la Información. Profesora del área de sociología, Universidad Rey Juan Carlos, Madrid, España. .
García García F; Doctor en Ciencias de la Información. Profesor Catedrático de Comunicación Audiovisual y Publicidad, Universidad Complutense de Madrid, Madrid, España. .; Pokaż więcej
Transliterated Title :: La sostenibilidad del sistema de salud y el mercado farmacéutico: Una interacción permanente entre el costo de los medicamentos, el sistema de patentes y la atención a las enfermedades.
Źródło :: Salud colectiva [Salud Colect] 2020 Oct 17; Vol. 16, pp. e2897. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji :: Journal Article
MeSH Terms :: Antiviral Agents*/economics
Antiviral Agents*/therapeutic use
Drug Costs*
Health Policy*
Patents as Topic*
Drug Industry/*organization & administration
Health Services Accessibility/*organization & administration
Virus Diseases/*drug therapy
Drugs, Generic ; Global Health ; Humans ; Pandemics ; Program Evaluation ; Virus Diseases/economics ; Virus Diseases/epidemiology ; Virus Diseases/prevention & control
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Research on technology prospect risk of high-tech projects based on patent analysis.
Autorzy :: Zhang L; School of Management and Engineering, Capital University of Economics Business, Beijing, China.
Liu Z; Research Center for Information Science Methodology, Institute of Scientific and Technical Information of China, Beijing, China.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Oct 05; Vol. 15 (10), pp. e0240050. Date of Electronic Publication: 2020 Oct 05 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Patents as Topic*
Research Design*
Data Mining ; Principal Component Analysis ; Technology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Autorzy :: Nascimento Junior JAC; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.; Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.
Santos AM; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.
Quintans-Júnior LJ; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.; Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.
Walker CIB; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.; Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.
Borges LP; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.
Serafini MR; Department of Pharmacy, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.; Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe , São Cristóvão, Sergipe, Brazil.; Pokaż więcej
Źródło :: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2020 Aug; Vol. 30 (8), pp. 567-579. Date of Electronic Publication: 2020 Jun 07.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Patents as Topic*
Antiviral Agents/*therapeutic use
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Middle East Respiratory Syndrome Coronavirus/*drug effects
Pneumonia, Viral/*drug therapy
SARS Virus/*drug effects
Severe Acute Respiratory Syndrome/*drug therapy
Animals ; Antiviral Agents/adverse effects ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Drug Development ; Drug Discovery ; Host-Pathogen Interactions ; Humans ; Middle East Respiratory Syndrome Coronavirus/pathogenicity ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/virology ; SARS Virus/pathogenicity ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/diagnosis ; Severe Acute Respiratory Syndrome/virology ; Treatment Outcome
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Microbiome therapeutics and patent protection.
Autorzy :: FitzGerald MJ; Nixon Peabody LLP, Boston, MA, USA.
Spek EJ; Vedanta Biosciences, Inc., Cambridge, MA, USA. .; Pokaż więcej
Źródło :: Nature biotechnology [Nat Biotechnol] 2020 Jul; Vol. 38 (7), pp. 806-810.
Typ publikacji :: Journal Article
MeSH Terms :: Patents as Topic*
Drug Industry/*trends
Microbiota/*drug effects
Humans ; Microbiota/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Patents, economics, and pandemics.
Autorzy :: Zerhouni W; Will Zerhouni is an intellectual property attorney, economist, entrepreneur, and former Assistant United States Attorney. .
Nabel GJ; Gary J. Nabel is the chief scientific officer of Sanofi Global R&D, Cambridge, MA, USA, and is the former and founding director of the Vaccine Research Center at the U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .
Zerhouni E; Elias Zerhouni is a professor at Johns Hopkins University, Baltimore, MD, USA, and is the former director of the National Institutes of Health and former President of Global R&D for Sanofi Global R&D, Cambridge, MA, USA. .; Pokaż więcej
Źródło :: Science (New York, N.Y.) [Science] 2020 Jun 05; Vol. 368 (6495), pp. 1035.
Typ publikacji :: Editorial
MeSH Terms :: Coronavirus Infections*
Financing, Government*
Pandemics*
Patents as Topic*
Pneumonia, Viral*
COVID-19 ; Humans ; Pathology, Molecular/economics ; Pharmaceutical Preparations/economics ; Vaccines/economics
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Protect against market exclusivity in the fight against COVID-19.
Autorzy :: 't Hoen E; Medicines Law & Policy, The Netherlands, . .; Pokaż więcej
Źródło :: Nature medicine [Nat Med] 2020 Jun; Vol. 26 (6), pp. 813.
Typ publikacji :: Journal Article
MeSH Terms :: Intellectual Property*
Patents as Topic*
Coronavirus Infections/*epidemiology
Coronavirus Infections/*therapy
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*therapy
Betacoronavirus/pathogenicity ; COVID-19 ; COVID-19 Vaccines ; Coronavirus Infections/prevention & control ; Coronavirus Infections/virology ; Humans ; Pandemics ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Viral Vaccines/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Downward Slide: REPORT SHOWS U.S. PATENT SYSTEM VEERS AWAY FROM PROTECTIONS FOR INNOVATORS.
Autorzy :: QUINN, GENE; Pokaż więcej
Temat :: PATENTS
PATENTABILITY
PATENT law
MARKETING research companies
ECONOMIC research
Źródło :: Inventors' Digest. Nov2020, Vol. 36 Issue 11, p43-45. 3p.
: Periodyk

Szczegóły Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Achieving greater independence from commercial influence in research.
Autorzy :: Lexchin J; School of Health Policy and Management, York University, Toronto, ON, Canada.; Department of Family and Community Medicine University of Toronto, Toronto, Canada.; University Health Network, Toronto, Canada.
Bero LA; Center for Bioethics and Humanities, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
Davis C; Department of Global Health and Social Medicine, King's College London, London, UK.
Gagnon MA; School of Public Policy and Administration, Carleton University, Ottawa, ON, Canada.; Pokaż więcej
Źródło :: BMJ (Clinical research ed.) [BMJ] 2021 Mar 09; Vol. 372, pp. n370. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomedical Research/*economics
Biomedical Research/*ethics
Clinical Trials as Topic/*economics
Clinical Trials as Topic/*ethics
Conflict of Interest/*economics
Research Support as Topic/*economics
Research Support as Topic/*ethics
Bias ; Biomedical Research/legislation & jurisprudence ; Conflict of Interest/legislation & jurisprudence ; Drug and Narcotic Control/legislation & jurisprudence ; Europe ; Humans ; Information Dissemination/ethics ; Information Dissemination/legislation & jurisprudence ; Patents as Topic/ethics ; Patents as Topic/legislation & jurisprudence ; Publishing/economics ; Publishing/ethics ; Publishing/legislation & jurisprudence ; Research Support as Topic/legislation & jurisprudence ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: GAPING GAP: MUCH WORK AHEAD IN HELPING MORE WOMEN AND MINORITIES GET PATENTS.
Autorzy :: CREAGER, REID; Pokaż więcej
Temat :: MINORITY women
PATENTS
Źródło :: Inventors' Digest. Mar2020, Vol. 36 Issue 3, p28-31. 4p.
: Periodyk

Szczegóły Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Quantity vs. quality: an assessment of the current pipeline for rabies.
Autorzy :: Neevel AMG; Athena Institute, VU University, Amsterdam, The Netherlands.; Viroclinics Biosciences, Rotterdam, The Netherlands.
Urias E; Athena Institute, VU University, Amsterdam, The Netherlands.; UNU-MERIT, Maastricht, The Netherlands.; Elabora Consultoria, São Paulo-SP, Brazil.
Claassen E; Athena Institute, VU University, Amsterdam, The Netherlands.
van de Burgwal LHM; Athena Institute, VU University, Amsterdam, The Netherlands.; Artemis One Health, Utrecht, The Netherlands.; Pokaż więcej
Źródło :: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2020 Apr; Vol. 25 (4), pp. 397-407. Date of Electronic Publication: 2020 Feb 06.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Clinical Trials as Topic*
Patents as Topic*
Rabies/*epidemiology
China/epidemiology ; Humans ; Rabies/prevention & control ; Rabies Vaccines ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: It's time to consider a patent reprieve for COVID vaccines.
Źródło :: Nature [Nature] 2021 Apr; Vol. 592 (7852), pp. 7.
Typ publikacji :: Editorial; Historical Article
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*economics
COVID-19 Vaccines/*supply & distribution
Developed Countries/*economics
Developing Countries/*economics
Drug Industry/*economics
Patents as Topic/*legislation & jurisprudence
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/transmission ; Cooperative Behavior ; Drug Industry/legislation & jurisprudence ; History, 20th Century ; Humans ; Licensure/legislation & jurisprudence ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; Penicillins/economics ; Penicillins/history ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; United Nations ; United States/epidemiology ; World Health Organization/organization & administration ; World War II
: Opinia redakcyjna

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Patents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język